Pharvaris N.V. (PHVS)
NASDAQ·Healthcare·Biotechnology
$28.23
-1.67%
Mkt Cap $1.91B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 2, 2026 | — | — | — | -$0.71 | -$0.85 | -18.34% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.78 | -$0.70 | +10.26% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.87 | -$0.94 | -8.05% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.80 | -$0.89 | -11.25% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | — | -$0.93 | — | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.66 | -$0.85 | -28.79% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.57 | -$0.59 | -3.51% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.56 | -$0.56 | +0.00% | — | — |
| Q2 2024 Apr 3, 2024 | — | — | — | -$0.58 | -$0.82 | -41.38% | — | — |
| Q4 2023 Nov 2, 2023 | — | — | — | -$0.67 | -$0.63 | +5.97% | — | — |
| Q3 2023 Aug 7, 2023 | — | — | — | -$0.71 | -$0.69 | +2.82% | — | — |
| Q2 2023 May 8, 2023 | — | — | — | -$0.81 | -$0.72 | +11.11% | — | — |
| Q2 2023 Apr 5, 2023 | — | — | — | — | -$0.73 | — | — | — |
| Q4 2022 Dec 8, 2022 | — | — | — | -$0.64 | -$0.25 | +60.94% | — | — |
| Q3 2022 Jul 1, 2022 | — | — | — | — | -$0.39 | — | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$0.49 | -$0.54 | -10.20% | — | — |
| Q1 2022 Mar 29, 2022 | — | — | — | -$0.74 | -$0.47 | +36.49% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.49 | -$0.46 | +6.12% | — | — |
| Q3 2021 Jul 30, 2021 | — | — | — | -$0.51 | -$1.13 | -121.57% | — | — |
| Q2 2021 May 26, 2021 | — | — | — | -$0.34 | -$0.66 | -94.12% | — | — |